Survival Benefit Achieved by Combining Rhu-pGSN with Meropenem
BioAegis Therapeutics Announces Study Indicating Gelsolin Treatment Improves Survival and Reduces Lung Injury in Antibiotic Resistant Pneumonia
September 03, 2020 21:42 ET | BioAegis Therapeutics
MORRISTOWN, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical stage, private company developing therapies for infectious, inflammatory and degenerative diseases through...
BioAegis Therapeutics LOGO 2.5 x 5 150 pixel.jpg
Independent Studies Confirm Low Levels of Immune System Protein, Gelsolin, Associated with COVID-19 Severity
August 17, 2020 10:57 ET | BioAegis Therapeutics
BioAegis Conducting COVID-19 Clinical Trial of Gelsolin Therapeutic MORRISTOWN, N.J., Aug. 17, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical stage, private company developing...
PMCB YT .png
Developer of PharmaCyte Biotech’s COVID-19 Test Explains Why His Test Is So Highly Sensitive, Path to FDA EUA, and Commercialization
April 20, 2020 09:00 ET | PharmaCyte Biotech
NEW YORK, NY, April 20, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) recently entered into a licensing agreement with Hai Kang Life Corporation (Hai Kang), where Hai Kang granted to...
logo_png.png
Canadian charity makes COVID-19 information accessible in local dialects
April 13, 2020 16:00 ET | LetsStopAIDS
TORONTO, April 13, 2020 (GLOBE NEWSWIRE) -- LetsStopAIDS, Canada’s youth-HIV charity, has created a platform to ensure that information about COVID-19 is available to vulnerable populations where...
PMCB YT .png
PharmaCyte Biotech to Offer COVID-19 Testing While Creating Revenue Stream for Pancreatic Cancer Program
April 13, 2020 09:00 ET | PharmaCyte Biotech
NEW YORK, NY, April 13, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) is a California-based biotechnology company focused on developing cellular therapies for cancer and diabetes using...
logo_png.png
COVID-19 information made accessible to vulnerable communities
April 09, 2020 06:00 ET | LetsStopAIDS
TORONTO, April 09, 2020 (GLOBE NEWSWIRE) -- LetsStopAIDS, Canada's Youth-HIV charity, has created a platform to ensure that information about COVID-19 is available to vulnerable populations where...
Healthcare worker training addresses personal protection against Coronavirus exposure
March 06, 2020 12:21 ET | Texas A&M Engineering Extension Service
COLLEGE STATION, TEXAS, March 06, 2020 (GLOBE NEWSWIRE) -- DHS/FEMA training for healthcare personnel on infectious diseases includes the latest information on the novel coronavirus, which has...
logo.jpg
Immunoscore in the WHO Classification of Digestive System Tumours
March 04, 2020 12:30 ET | HalioDx
Immunoscore® in the WHO Classification of Digestive System Tumours Immune response is  now part of the Essential and Desirable Diagnostic Criteria for Colorectal Cancers in the 5th edition of the...
dynavax_logo_notagline.jpg
Dynavax Announces Collaboration with the University of Queensland and the Coalition for Epidemic Preparedness (CEPI) Focused on the Development of a Coronavirus (COVID-19) Vaccine
March 02, 2020 08:00 ET | Dynavax Technologies Corporation
EMERYVILLE, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today...
Two internationally recognized health standards organizations join the effort to manage an escalating global public health emergency
February 13, 2020 11:00 ET | SNOMED International
London, United Kingdom, Feb. 13, 2020 (GLOBE NEWSWIRE) -- The world is focused on the outbreak of respiratory illness caused by a novel coronavirus.  The World Health Organization (WHO) has named...